Introduction
Membrane protein crystallography requires complex systems to drive the formation of highquality crystals. Lipid self-assembly systems have had some success in providing crystallization media for transmembrane proteins (TMPs) via the technique of in meso crystallization [1] . The technique is particularly useful for solving the structure of membrane proteins which are important as drug targets; more than 60% of currently available pharmaceutical compounds on the market target TMPs [2, 3] . The structures of approximately 200 membrane proteins and peptides have been solved to date using in meso crystallization [4] [5] [6] [7] . However, this represents just 1% of all structures in the Protein Data Bank (PDB), while it is predicted that in most organisms membrane proteins represent 20-30% of the proteins produced [8, 9] . Success rates for crystallization of TMPs are improving; almost half of all membrane protein structures solved using the in meso method have been added to the PDB in the last 3 years [7] . Recent advances involve the use of an X-ray free-electron laser set-up [10, 11] for analysing in meso derived micro-/nano-crystals. However, this method is experimentally complex and not yet widely available. The mechanisms underlying the lipid-protein interactions that contribute to the formation of high-quality crystals remain poorly resolved, contributing to low overall success rates [4, 6, 12] . Ultimately, successful membrane protein structure determination requires an advanced understanding of the lipid microenvironment that enables crystal formation. Nevertheless, there is very limited ongoing research in this field [13] [14] [15] .
Modelling studies initially suggested that suitable targets for in meso crystallization would need to include a minimum of five transmembrane helices [16] . However, this has been recently challenged by successful use of the method to solve the structures of the transmembrane peptide gramicidin, which forms a double helix or helical dimer, as well as DAP12-TM and the designed peptide Rocker, which are single transmembrane α-helices [5, [17] [18] [19] . The single transmembrane α-helix DAP12 was selected to observe crystal growth in this study. DAP12 is the signalling module of immunoreceptor complexes that are involved in a broad array of biological functions. Blockade of DAP12-dependent signals forms a new therapeutic approach for the regulation of inflammatory host responses, as it is involved in chronic inflammatory diseases [20] . The structure of the transmembrane domain of DAP12 is needed to develop comprehensive mechanistic models of the multi-subunit membrane protein complexes. DAP12 is a 12 kDa signalling peptide of 113 amino acids and the transmembrane domain is formed by 24 amino acid residues within the sequence [21, 22] . The structure of the helical transmembrane portion (DAP12-TM; total 33 amino acids) has been determined in several different oligomeric forms using solution NMR [ [19] .
recently using in meso crystallization [19] ; the structure of the tetramer is shown in figure 1 . The crystallographic space group of this structure is P2 1 [19] .
The most commonly used lipid phases for in meso crystallization are bicontinuous cubic phases (Q II ) [23] [24] [25] [26] . They consist of a lipid bilayer draped across a periodic minimal surface of zero mean curvature (figure 2 [27, 28] ). The three experimentally observed cubic mesophases are the diamond (Q II D ), primitive (Q II P ) and gyroid (Q II G ) cubic phases.
Cubic phases are an ideal medium for the encapsulation of soluble, peripheral and TMPs for in meso crystallization [26] . They are the only lipidic self-assembly material to contain a continuous bilayer structure over three dimensions. Cubic phases also have large surface area to volume ratios and therefore the ability to incorporate relatively large amounts of protein [26, 29] grown in meso have been found to be robust and of high quality and TMPs crystallized within a lipidic cubic phase are more likely to retain their activity [30] . For in meso crystallization, monoolein (MO) is the most commonly used lipid to date [5, 7, 31] . It has a monoglycerol head group and a singly unsaturated C18 hydrocarbon chain. It forms a robust diamond cubic Q II D phase in excess water and at room temperature (lattice parameter approx. 105 Å) and is readily available at relatively low-cost [32, 33] . MO cubic phases are commonly doped with 5-10% w/v cholesterol for in meso crystallization [5, 34] . The proposed mechanism of membrane protein crystallization within the lipidic mesophase suggests that the protein is initially uniformly dispersed in the cubic phase but that the crystals grow from a local lamellar phase, which acts as a conduit between the crystal and the bulk cubic phase [35, 36] . However, evidence for this mechanism relies on a single experimental study on one membrane protein, bacteriorhodopsin, carried out in 2007. The study, using micro-focused X-ray diffraction (XRD), showed that diffraction from the lamellar phase was only observed at the interface between the crystals and the cubic phase and not in the bulk cubic phase. The proposed mechanism is supported by indirect evidence, including the layered, Type I, crystal packing displayed by all membrane proteins crystals formed in meso [7] , freeze-fracture electron microscopy (EM) studies on acetylcholine-receptor microcrystals [14] and atomic force microscopy (AFM) on bacteriorhodopsin (bR) crystals [15] . However, in the past 8 years, no additional direct experimental evidence on the highly localized cubic-lamellar transition, which is thought to occur during crystal growth, has been obtained. This may reflect the intrinsic complexity of the original experiment. A specially designed sample cell (20 μm thick) and a micro-focused (400 and 5 μm diameter) X-ray beam were used; major problems with radiation damage were encountered. In addition, analysis of the experimental results was complicated by the addition of the detergent octyl glucoside (OG) which in itself can induce lamellar phase formation [13] .
Herein we describe an updated, relatively non-complex, experimental protocol to investigate the localized microenvironment around crystals grown in meso. Crucially, this should allow the proposed mechanism to be tested on numerous membrane proteins and peptides, to confirm whether the proposed mechanism is generally applicable. Standard commercially available 96-well sandwich plates (100 μm spacing) and a standard set-up for small angle Xray scattering (SAXS) measurements were used. Multiple SAXS spectra were acquired to sample the surface of each well using a beam size of 50 × 50 μm and a step size of 25 or 37.5 μm.
No detergent was used for solubilization of the peptide [18, 19] which reduced the complexity of the system further. Problems with radiation damage were not encountered and very goodquality data were obtained. In this study, the local microenvironment around crystals of the single transmembrane α-helix DAP12-TM [19] was investigated using synchrotron SAXS. The experimental conditions (crystals were grown from the MO cubic phase doped with 5% w/v cholesterol) were based on those recently used to solve the structure of the DAP12-TM peptide using in meso crystallization [19] . 
Material and methods (a) Materials
MO was obtained from Nu-Check Prep, Inc. (Waterville, MN, USA). Cholesterol and hexafluoroisopropanol (HFIP) were purchased from Sigma-Aldrich (St Louis, MO, USA). Hamilton syringes were purchased from Hamilton Company (Reno, NV, USA) and syringe couplers from TTP Labtech (Cambridge, MA, USA). The 96-well Laminex UV plastic plates and Laminex UV plastic covers were bought from Molecular Dimensions (Suffolk, UK). All crystallization chemicals with greater than 99.9% purity were sourced from Sigma-Aldrich. Lysozyme (L6876) was dissolved into a solution of 50 mM sodium chloride with 50 mM tris chloride at pH 7.0 (again greater than 99.9% purity sourced from Sigma-Aldrich).
(b) DAP12-TM peptide production and purification
The disulfide-linked human DAP12-TM peptide CSTVSPGVLAGIVVGDLVLTVLIALAVYFLGRL was produced in Escherichia coli and purified following the published procedure [37] . The peptide was aliquoted and stored as a lyophilized product.
(c) Plate set-up DAP12-TM was weighed and mixed with MO and 5% w/v cholesterol in a microfuge tube. A homogeneous solution was obtained by adding 500 μl of HFIP with brief vortexing and gentle heating. The sample was frozen in liquid nitrogen and then lyophilized overnight.
The peptide/lipid mixture was heated to 50 • C to melt the lipid and loaded into a 100 μl Hamilton syringe. Using a second syringe loaded with water and a syringe coupler, the peptide/lipid mixture was mixed until homogeneous with ultrapure water to achieve 40% w/w final water content. The peptide-containing mesophase was loaded in the 96-well sandwich crystallization plate (100 μm spacing, 0.2 μl per well) and a precipitant solution was deposited on top (1 μl per well) using the Mosquito LCP robot (TTP Labtech) based at the Collaborative Crystallization Centre (C3), CSIRO, Parkville, Australia. Plates were sealed and kept at 20 • C in a Gallery 700 incubator coupled to a Minstrel HTUV imaging system (Rigaku, The Woodlands, TX, USA) [38] . The DAP12-TM crystals were imaged using an Eclipse 80i microscope (Nikon Instruments, Melville, NY, USA) 5 days after plate set-up. DAP12-TM was crystallized at a final concentration of 10 mg ml −1 in MO with 5% w/v cholesterol using 96 different screen conditions within this range: 0.1 M bis-tris propane chloride (pH 6.2-6.4), 19-22% w/v polyethylene glycol (PEG) 3350 and 0.03-0.07 M calcium chloride [19] .
In the case of lysozyme, a similar procedure was followed but MO was loaded into one 100 μl Hamilton syringe and lysozyme at 10 mg ml −1 in 50 mM sodium chloride with 50 mM tris chloride at pH 7.0 was loaded in the second syringe. Mixing, plate set-up and crystal growth monitoring were performed as for DAP12-TM. Lysozyme crystallized in the presence of MO under three different crystallization conditions was used: the first condition was 1.0 M sodium chloride and 0.1 M sodium acetate-acetic acid (pH 4.5). The second condition was 1.1 M sodium malonate-malonic acid (pH 7.0), 0.5% w/v jeffamine ED-2001 (pH 7.0) and 0.1 M sodium HEPES (pH 7.0). The third condition was 20% w/v PEG 6000, 0.1 M trisodium citrate-citric acid (pH 4.0), 1.0 M lithium chloride.
(d) Small angle X-ray scattering measurements
Structural analysis was performed at the SAXS/WAXS beamline at the Australian Synchrotron [39] . The plates were inserted into a custom-designed, temperature-controlled plate holder for data acquisition. Data were collected at 20 • C, 4 or 5 days after the DAP12-TM and lysozyme crystallization plates were prepared. Scanning of the plates and mapping within individual wells was fully automated. Data were obtained using an X-ray wavelength of 1.12713 Å (11.0 keV), beam dimensions of approximately 50 × 50 μm, a typical flux of 1 × 10 10 photons s −1 and an exposure time of 5.0 s. Two-dimensional diffraction images were recorded on a Pilatus 1 M detector, which offers very low noise and rapid data collection over a large active area. Radial averaging of the two-dimensional images produced one-dimensional scattering profiles, with the added benefit of overcoming dead space resulting from intermodule gaps.
(e) Small angle X-ray scattering data analysis Ordered nanostructured lyotropic liquid crystalline phases with distinct diffraction patterns were studied. Many orders of diffraction were observed despite the small sample size, allowing unambiguous identification of the cubic phase. The high-throughput analysis program RapidPhaseIdent that was developed at the SAXS/WAXS beamline of the Australian Synchrotron, as described in a recent article [40] , was used for lipid mesophase and lattice parameter identification along with the IDL-based AXCESS software package, developed at Imperial College London [41] .
The one-dimensional diffraction patterns were normalized to the beam transmitted through the sample as measured by a detector mounted in the beamstop [39] . Peak areas were determined by fitting a Gaussian with four terms within a specific q-range for each peak. This was achieved in a high-throughput fashion using a dedicated feature within the SAXS data reduction software named 'scatterBrain' [42] . ScatterBrain is developed and maintained by Dr Stephen Mudie at the Australian Synchrotron.
The one-dimensional diffraction patterns presented in this paper were scaled to correct for small differences in sample thickness and density observed as shifts in intensity. A simple utility was developed to calculate the mean intensity of each profile, ignoring the peak regions and in turn calculate a simple multiplicative factor to align each sample to a nominal profile. All intensities are relative (no absolute intensity calibration was performed or required).
Results and discussion
The DAP12-TM tetrameric crystal structure, recently solved to 2.14 Å resolution, is shown in figure 1 [19] . Crystals with Type I crystal packing were grown from MO with 70 mg ml −1 DAP12-TM, 0.1 M bis-tris propane chloride (pH 6.07), 19.7% w/v PEG 3350 and 0.269 M calcium chloride [19] . The peptide concentration could be reduced to 10 mg ml −1 , the concentration used in this study, while still enabling successful crystal growth. X-ray diffraction studies on a significant number of crystals grown at 70 and 10 mg ml −1 DAP12-TM showed that all crystals grown in crystallization screen conditions with calcium had the same space group and unit cell. The crystallographic space group was P2 1 2 1 2 with unit cell dimensions of 50.8 Å, 43.7 Å, 50.6 Å, 90 • , 90 • , 90 • [19] .
The microenvironment around the DAP12-TM crystals was investigated using synchrotron SAXS analysis with a micro-sized beam approximately 50 × 50 μm in size. Under excess water conditions and with no crystallization screen components, MO with 5% w/v cholesterol and final concentration of 10 mg ml −1 DAP12-TM (0.05 mole%) formed a Q II D with a lattice parameter of 10.4 nm after 5 days incubation. The DAP12-TM peptide did not significantly affect the lipid mesophase formed at this concentration, since similar values are reported in the literature for MO in excess water [32, 33] . The presence of 5% w/v cholesterol also had little impact on the lattice parameter, in agreement with a previous study [43] . DAP12-TM crystals (grown with 19-22% w/v PEG 3350 as precipitant, 0.03-0.07 M calcium chloride as salt additive and 0.1 M bis-tris propane chloride (pH 6.2-6.4) as buffer) were studied after 4 days incubation at 20 • C. While these conditions are not identical to those used to solve the structure in figure 1 , XRD analysis of the crystals grown under these conditions confirmed that they have an identical space group and unit cell parameters. In 78% of the 96 wells, crystal growth was observed within the incubation period. On average 30- a length of around 60 μm were observed per well, together with up to 10 star-shaped fractal crystals with a diameter of around 60 μm. Fractal aggregates can form during nucleation [44] , leading to fractal crystals when followed by rapid crystal growth. The fractal crystals were easier to locate because of their size and for this reason the microenvironment around fractal crystals was preferentially chosen for analysis.
The majority of wells where crystal growth was observed adopted a Q II G , with a typical lattice parameter of approximately 12.1 nm (73% of wells). For 24% of wells, the major phase was the Q II D with a lattice parameter of around 8.6 nm, and in 3% of wells no diffraction was observed. In some cases, a minor coexisting phase of cubic or lamellar symmetry was observed. We found no significant difference in the distribution of lipid mesophases for those wells where no crystal growth was observed. Formation of the less-hydrated Q II G phase, as the major phase upon the addition of a crystallization screen containing PEG 3350 at 19%-22% w/v, is consistent with previous studies on the dehydrating effect of PEG on lipid mesophases [40, [45] [46] [47] . Indeed PEG 3350 at 20% w/v was found to dehydrate the Q II D formed by MO in excess water to the Q II G by causing a reduction in water activity [40] . These data confirm that successful DAP12-TM crystal growth indeed occurred from a bulk cubic mesophase. The lipid microenvironment around the growing crystals was scanned to assess the proposed mechanism of in meso crystallization. An array of 9 × 9 data points in the X-and Y-directions over a total area of either 300 × 300 μm (37.5 μm step size) or 200 × 200 μm (25 μm step size) was scanned around DAP12-TM crystals. The microenvironment around 72 DAP12-TM crystals (in 17 areas) was analysed. Two areas without crystals were analysed as negative controls. The microenvironment around four lysozyme crystals (in three areas), also grown in meso, was analysed as a second negative control. For soluble proteins like lysozyme, crystal growth is not expected to occur from the cubic mesophase via a lamellar conduit as these proteins do not embed within the lipid bilayer. For these negative controls, an array of 7 × 7 data points in the X-and Y-directions was analysed over an area of 300 × 300 μm (50 μm step size).
An example of the 81 aligned one-dimensional diffraction patterns of a scanned area of 300 × 300 μm is shown in figure 3a . All patterns show a Q II G with a lattice parameter of 12.5 nm as the major mesophase, as indicated by the observed
and √ 26 reflections. The reflections indicate that the structure of the cubic phase is highly homogeneous over the entire surface of the well. Additional peaks were observed in a number of plots at qvalues of 0.123 and 0.477 Å −1 as indicated in figure 3a with the blue and red arrows, respectively. The peak at q = 0.123 Å −1 is typical of the first-order reflection of the fluid lamellar phase (L α ) of MO. We do not observe the second-order reflection from the L α . However, this peak, which is of much lower intensity than the first-order reflection, is coincident with the √ 22 peak from the Q II G phase which may preclude its observation. The lattice parameter of the putative L α phase is 5.1 nm, typical for the L α phase formed by MO [32, 33] . The observed L α phase reflections were single or double spots of localized intensity located 180 • apart as shown by the blue arrows in figure 3b (see enlargement in inset) rather than isotropic reflections or rings. This indicates that the lamellar phase observed is highly oriented in one or two directions and is consistent with the co-location of the lipid lamellar phase at a crystal face. The localized spots were located at different positions with respect to the beamstop for different crystals, in line with the randomly oriented nature of the growing crystals.
We suggest that the peak observed at wider angle (q = 0.477 Å −1 correlating to a distance of 1.3 nm) is associated with the DAP12-TM crystal packing and refer to this as the crystal peak. This peak could be related to non-crystallographic symmetry of the DAP12-TM chains. The tetrameric structure contains four chains arranged as two dimers (figure 1), and a typical distance between chain centres is 1.3 nm. The non-crystallographic symmetry operators are shown in the electronic supplementary material, S1.
The phase distribution around the growing crystals was assessed via the relative intensity of three separate peaks observed at q-values of 0.123, 0.129 and 0.477 Å −1 . These peaks represent the first-order L α phase reflection, the √ 6 peak from the Q II G phase and a putative chain packing peak from the crystal, respectively. Figure 4 . Peak intensity measured across the 300 × 300 μm sample area of the one-dimensional-diffraction patterns in figure 3 . Separate maps are provided for (a) the Q II G peak ( √ 6, q = 0.129 Å −1 ), (b) the DAP12-TM crystal peak (q = 0.477 Å −1 ) and (c) the L α peak ( √ 1, q = 0.123 Å −1 ). SAXS patterns were taken after 4 days incubation. In (d), an optical image of the scanned area, taken after 5 days incubation, is shown. The area within the black box is the investigated area of 300 × 300 μm.
In (e) an overlay of (a-d) is shown; image (a,b,c) are shown with increasing transparency on top of image (d).
the X-ray beam (50 × 50 μm) is also shown. In figure 4 , colour maps representing the intensity of the three different phases (cubic, crystal and lamellar, figure 4a-c) are directly overlaid with an optical image of the crystals, figure 4d. This allows for easy visual correlation of the co-localization of the crystals with each phase, figure 4e.
The map of Q II G peak intensity, shown in green in figure 4a, is relatively homogeneous over the scanned area. The lattice parameter of this phase is also constant. This indicates that the cubic phase is highly homogeneous over the surface of the well, both in lattice parameter and relative concentration. The domains of the cubic phases analysed were smaller than 50 μm (the beam size) since powder diffraction rings (figure 3b) were observed instead of discrete Bragg reflections. DAP12-TM crystals of up to 60 μm length and diameter formed indicating that peptide must be transported from multiple domains to the growing crystals. The maps of the crystal peak intensity in red (q = 0.477 Å −1 , figure 4b ) and L α peak intensity in blue (q = 0.123 Å −1 , figure 4c) are heterogeneous with localized areas of intensity. In the overlay image in figure 4e , the intensity of Q II G is shown in green, the crystal peak in red and the L α phase in blue on top of the visible crystals (figure 4d) with increasing transparency. Areas with both the crystal peak and L α peak show up as purple. The green colour representative of the Q II G is not always visible due to the other overlaying images. Figure 4e shows that the L α phase signature was only present close to one of the DAP12-TM crystals. The intensity of the L α peak was highest towards the edge of the crystal, suggesting that the lamellar phase is concentrated in this area. This distribution in intensity, with the lamellar phase concentrated towards the edges of the crystal, was clearly observed in additional scans of the microenvironment around growing crystals; see for example figure 6c and the electronic supplementary material, figures S2.4 and S2.8. In figure 4c , electronic supplementary material, figures S2.4(C) and S2.8(C), an arrow shows the intensity gradient. The observation is consistent with the theory of a highly oriented lipid lamellar phase conduit between the cubic phase and the crystal and provides supporting evidence for the proposed mechanism of in meso crystallization. That is, we suggest that the Type I packing DAP12-TM crystals with a lamellar spacing of 5.1 nm grew from the Q II G via a highly oriented lipid lamellar L α phase with a lattice parameter of 5.1 nm. This result is consistent with the previous finding that the transition from a lamellar fluid mesophase to an inverse bicontinuous cubic mesophase can be a low-energy transformation process [48] . It can also be seen in figure 4e that the areas where the crystal peak was observed correlated well with the presence of visible crystals, linking the diffraction peak at 0.477 Å −1 with the DAP12-TM crystals. In this scan, three out of four crystals observed showed the crystal peak.
Two additional peaks at wider angles were consistently observed in numerous SAXS scans at 0.587 and 0.677 Å −1 and were also found to be associated with the DAP12-TM crystals. The three crystal peaks (q = 0.477, 0.587 and 0.677 Å −1 ) for the DAP12-TM crystals correlate to a distance of 1.3, 1.1 and 0.9 nm, respectively. As mentioned above, the crystal peaks could be related to non-crystallographic symmetry of the DAP12-TM chains. These peaks correlate well with typical distances between chain centres, which are 1.3, 1.1 and 1.0 nm. An example of the 81 diffraction patterns of an SAXS scan with all three crystal peaks is shown in figure 5a (see inset for enlargement of area with crystal peaks). Additional small peaks seen in the q-range 0.4-0.7 Å −1 were not consistently observed and are assumed to be noise. Analysis of the intensity of the three crystal peaks, shown in red, cyan and yellow in figure 5b, confirmed that they all correlated with the two visible crystals. The screen conditions in all wells studied were very similar, so that DAP12-TM crystals with the same space group and unit cell formed under all conditions. The crystal peak at q = 0.477 Å −1 was most frequently observed and had the highest intensity, and this peak was therefore used for subsequent analyses.
Three additional representative examples from SAXS scans around visible DAP12-TM crystals are shown in figure 6 . The remaining images from all scans around DAP12-TM crystals and the results of the negative controls are provided in the electronic supplementary material, S2. A similar distribution of phases was observed for all wells studied. Again, the crystal and lamellar peaks were invariably associated with the visual observation of crystals.
The lipid mesophase microenvironment was analysed around 72 DAP12-TM crystals as summarized in table 1 (see remaining images in the electronic supplementary material, S2, figures S2.1-S2.16). We note that the location of 50% of crystals was coincident with the crystal peak. Only approximately one in four crystals (24%) coincided with the lamellar peak. For 11% of DAP12-TM crystals analysed both the crystal peak and L α peak were observed, while 38% of crystals did not show either peak. We note that for wells with no crystal growth, neither the lamellar peak nor the crystal peak was observed at any point (see the electronic supplementary material, S2, figures S2.17 and S2.18).
In summary, the presence of the lamellar and crystal peaks was invariably associated with the visible observation of a crystal; the peak corresponding to the crystal phase was coincident with the observation of the crystal, whereas the lamellar peak appeared to be concentrated at the edges of the crystal. However, these peaks were not observed for every crystal. We note no correlation between the presence of the lamellar and/or crystal peaks and the rate of crystal growth. The crystal growth from 3 h until 7 days for the sample shown in figure 4 , recorded by the automated Minstrel HTUV imaging system, is shown in figure 7 . Crystal growth appears to have slowed down significantly after 2 days for all crystals. SAXS analysis was performed after 4 days. It is possible that some crystals may have already phase-separated from the cubic phase with the loss of the lamellar phase conduit. The highly oriented lamellar phase may also not be in the correct orientation for diffraction for all crystals. The plane of the lamellae and the X-ray beam must be parallel for diffraction to occur, as was reported for the bR crystals [13] . Finally, the absence of the lamellar peak for some crystals may reflect the low intensity of this peak.
For the lysozyme scans, 75% of crystals co-localized with a crystal peak at q = 0.506, 0.705 or 0.721 Å −1 (electronic supplementary material, S2, figure S2.19-S2.21) which correlates to a distance of 0.9-1.2 nm. For lysozyme, each originates from a different crystal packing, whereas for DAP12-TM the three crystal peaks are believed to originate from a single crystal. The lysozyme crystals observed might have a different crystallographic space group and unit cell as they were grown with significantly different crystallization screen conditions. All DAP12-TM crystals were grown with very similar screen conditions and had the same space group and unit cell. This result suggests that different types of peptide and protein crystals can lead to diffraction peaks at wide angles. None of the lysozyme crystals co-localized with a local lamellar phase, as expected for proteins that crystallize in the aqueous phase rather than from the lipid bilayer under conditions of in meso crystallization [49, 50] . Crystal peaks were not observed for all DAP12-TM and lysozyme crystals. As for the L α phase, the crystals may not always be in the correct orientation to result in crystal peak diffraction at wide angles. The absence of the crystal peaks for some crystals may also reflect the low intensity of these peaks. Images shown here are taken with the Minstrel HTUV imaging system [38] . These crystals were used for SAXS analysis, as shown in figures 3 and 4. Table 1 . Data are provided for the total number of crystals analysed, the number of crystals that are co-localized with a crystal peak (crystal peak), the number of crystals that are co-localized with a lamellar peak (L α peak), the number of crystals that are co-localized with both a lamellar and a crystal peak (crystal + L α peak) and the number of crystals where neither a lamellar nor a crystal peak was observed (no Crystal or L α peak). Data are presented as a summary of all crystals observed, and for two control areas where no crystals were observed. Data are also provided for the growth of four lysozyme crystals. In addition, we have provided a summary of data for the four images shown in figures 4 and 6a-c, respectively. Crystals with more than 50% of the area of the crystal present in the region sampled by the X-ray beam were counted. A The highly oriented local L α phase of MO with lattice parameter of around 5.1 nm that was observed at the edge of 24% of DAP12-TM crystals provides support for the proposed mechanism for in meso crystallization [13, 35] . The crystal packing in the DAP12-TM crystals also showed a [19] , suggesting the crystals could grow via the lipid L α phase conduit. This represents the first direct comparison of the spacing between layers in Type I crystals with the lattice parameter of the lipid L α phase conduit. A local L α phase with similar lattice parameters was observed around bacteriorhodopsin crystals that were grown from the MO cubic phase [13] .
Conclusion
Crystallization of the transmembrane DAP12-TM peptide was found to be consistent with crystal growth occurring from the gyroid cubic mesophase via a highly oriented local lipid lamellar phase. The lamellar spacing of the Type I DAP12-TM crystals matched remarkably well with the lattice parameter of the lipid lamellar phase observed. In the negative controls, the local lamellar phase was not observed. A direct observation of the local lamellar phase using SAXS has only previously been reported for a single TMP (bacteriorhodopsin). The observation of a localized lamellar phase reported here for the transmembrane peptide DAP12-TM crystals provides important additional experimental evidence as to the generality of the proposed mechanism. An improved understanding of this promising in meso crystallization technique might lead to a more rational design of crystallization experiments and improved success rates. The results presented indicated that peptide from multiple cubic phase domains was transported to the growing crystals. A new observation of this study was that DAP12-TM and lysozyme crystals can give rise to diffraction peaks at wide angles. This is of potential use in locating peptide or protein crystals in the lipidic cubic phase as they are generally hard to observe. The experiment presented here used commercially available 96-well crystallization plates and a standard set-up for synchrotron SAXS measurements which will enable further testing of the proposed mechanism on a variety of TMPs and peptides as it can readily be adapted by other research groups. Additionally, the DAP12-TM peptide was co-lyophilized with MO and cholesterol and no detergent was used for solubilization which reduced the complexity of the system further.
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